These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 30793158)

  • 1. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
    J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
    Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
    Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
    Huang Y; Chen J; Yang S; Tan T; Wang N; Wang Y; Zhang L; Yang C; Huang H; Luo J; Luo X
    Drug Des Devel Ther; 2020; 14():4625-4637. PubMed ID: 33154629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway.
    Wang S; Zhang D; Han S; Gao P; Liu C; Li J; Pan X
    Sci Rep; 2017 Jul; 7(1):6215. PubMed ID: 28740094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziyuglycoside II, a triterpene glycoside compound in Sanguisorbae officinalis l. extract, suppresses metastasis in osteosarcoma via CBX4-mediated Wnt/β-catenin signal pathway.
    Deng Z; Yuan J; Ma B; Zhu J; Yan B; Wei J; Jin X; Li J; Zhang Q; Ma B
    Phytomedicine; 2024 Sep; 132():155716. PubMed ID: 38924929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
    Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y
    Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
    Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
    Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
    Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
    Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway.
    Wu BQ; Cao Y; Bi ZG
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3185-3192. PubMed ID: 28770967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis.
    Lillo Osuna MA; Garcia-Lopez J; El Ayachi I; Fatima I; Khalid AB; Kumpati J; Slayden AV; Seagroves TN; Miranda-Carboni GA; Krum SA
    Cancer Res; 2019 Mar; 79(6):1054-1068. PubMed ID: 30593524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
    Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
    Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euxanthone Impairs the Metastatic Potential of Osteosarcoma by Reducing COX-2 Expression.
    Chen X; Deng M; Zhou X; Wang X; Ye Y; Zhu J; Jiang H; Chen X; Zha W
    Anat Rec (Hoboken); 2019 Aug; 302(8):1399-1408. PubMed ID: 30334373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
    Zhang RX; Li Y; Tian DD; Liu Y; Nian W; Zou X; Chen QZ; Zhou LY; Deng ZL; He BC
    Int J Oncol; 2016 Nov; 49(5):1973-1982. PubMed ID: 27665868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
    Nanni P; Landuzzi L; Manara MC; Righi A; Nicoletti G; Cristalli C; Pasello M; Parra A; Carrabotta M; Ferracin M; Palladini A; Ianzano ML; Giusti V; Ruzzi F; Magnani M; Donati DM; Picci P; Lollini PL; Scotlandi K
    Sci Rep; 2019 Aug; 9(1):12174. PubMed ID: 31434953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.